Skip to content

Clinical trials

Enrolling by invitation Observational trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Status: Enrolling by invitation Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20151
20161
20181
20191
20201
20212
20221
20233
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Western Sydney Local Health District4
Alexion Pharmaceuticals, Inc.1
Allotera Therapeutics1
Australian and New Zealand Intensive Care Research Centre1
BioMarin Pharmaceutical1
CRISPR Therapeutics AG1
Center for Eye Research Australia1
Changi General Hospital1
Duke University1
Endogenex, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus2
Hematologic Neoplasms2
Acute Kidney Injury1
Angioedemas, Hereditary1
Autoimmune Diseases1
Blood Coagulation Disorders1
Blood Coagulation Disorders, Inherited1
Bone Diseases1
Choroideremia1
Coagulation Protein Disorders1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.